14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene,
SB1317,
TG02,
SB1317,
TG02,
TG-02,
937270-47-8,
1204918-72-8,
CHEMBL1944698,
UNII-40D08182TT,
40D08182TT,
SB-1317,
C23H24N4O,
14-Methyl-20-oxa-5,7,14,27-tetraazatetracyclo [19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene,
Tube011,
SB-1317 free base,
SCHEMBL823947,
TG02 [WHO-DD],
GTPL9095,
SCHEMBL2298965,
SCHEMBL17595943,
EX-A239,
14-methyl-20-oxa-5,7,14,27-tetraazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene,
AOB87361,
BCP07033,
4029AH,
BDBM50363196,
MFCD22124499,
ZINC68251500,
AKOS032950000,
SB1317(TG-02),
CS-0884,
SB14606,
compound 26h [PMID: 22148278],
HY-15166,
A11962,
W-5884,
(E)-6-methyl-12-oxa-3,6-diaza-2(4,2)-pyrimidina-1,4(1,3)-dibenzenacyclododecaphan-8-ene,
14-Methyl-20-oxa-5,7,14,26-tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene,
TG02 (Double bond E),
A3794,
A13454,